Cargando…
Disclosure of Adverse Events in the United States and Canada: An Update, and a Proposed Framework for Improvement
There is consensus that physicians, health professionals and health care organizations should discuss harm that results from health care delivery (adverse events), including the reasons for harm, with patients and their families. Thought leaders and policy makers in the USA and Canada support this g...
Autores principales: | Wu, Albert W., Boyle, Dennis J., Wallace, Gordon, Mazor, Kathleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147741/ https://www.ncbi.nlm.nih.gov/pubmed/25170503 http://dx.doi.org/10.4081/jphr.2013.e32 |
Ejemplares similares
-
Disclosure of Adverse Events: A Guide for Clinicians
por: Peterson, Kimberly A., et al.
Publicado: (2019) -
Glimpses of Canada and the United States
por: Boyle, A. Helen
Publicado: (1921) -
Rosiglitazone use and associated adverse event rates in Canada: an updated analysis
por: Iczkovitz, Sandra, et al.
Publicado: (2015) -
Proposal for an updated seizure classification framework in clinical trials
por: Steriade, Claude, et al.
Publicado: (2022) -
Open disclosure of adverse events: exploring the implications of service and policy structures on practice
por: Harrison, Reema, et al.
Publicado: (2019)